4th international conference on translational medicine...kaoutar ennour-idrissi, laval university,...

4
409 th OMICS Internaonal Conference Translational Medicine Scientific Program October 26-28, 2015 Baltimore, USA 4 th International Conference on OMICS Internaonal Conferences: 2360 Corporate Circle, Suite 400 Henderson, NV 89074-7722, USA Ph: +1-888-843-8169, Fax: +1-650-618-1417, Toll free: +1-800-216-6499 Email: [email protected]; [email protected]

Upload: others

Post on 05-Feb-2021

36 views

Category:

Documents


0 download

TRANSCRIPT

  • 409th OMICS International Conference

    Translational MedicineScientific Program

    October 26-28, 2015 Baltimore, USA

    4th International Conference on

    OMICS International Conferences:2360 Corporate Circle, Suite 400 Henderson, NV 89074-7722, USA Ph: +1-888-843-8169, Fax: +1-650-618-1417, Toll free: +1-800-216-6499

    Email: [email protected]; [email protected]

  • Page 2

    08:00-09:00 Registrations

    Chesapeak Hall

    Day 1 October 26, 2015

    Group PhotoTrack 4: Translational Therapeutics and Technologies Track 5: Translational Modeling of Efficacy and Safety Track 8: Clinical and Translational Oncology Track 9: Immunology and Infectious DiseasesSession Chair: Sergey Suchkov, Moscow State Medical University, RussiaSession Co-Chair: Jan Scicinski, EpicentRx Inc., USA

    Session Introduction

    11:10-11:35Antibody-proteases as promising tools of novel generation to be translated into clinical practice for having multistep (subclinical and clinical) demyelination monitoring securedSergey Suchkov, I M Sechenov First Moscow State Medical University, Russia

    11:35-12:00 Use of engineered mesenchymal stem cells against cancerIsabelle de Waziers, Paris Descartes University, France

    12:00-12:25 Identification of genetic variations associated with outcome risk in colorectal cancer: Where are we now?Sevtap Savas, Memorial University of Newfondland, Canada

    12:25-12:50RRx-001, a novel ROS-mediated epigenetic modulator: ‘Episensitization’ to previously failed therapies Jan Scicinski, EpicentRx Inc., USA

    Lunch Break 12:50-13:50 @ Eden's Landing Restaurant

    13:50-14:15From chromosomal instability to metastases- H19’s role in cancer progression and its clinical significance Eli Raveh, Hebrew University of Jerusalem, Israel

    14:15-14:40 Survivin si-RNA nano particles are capable of inhibiting cancer cell growth both in vitro and in vivoSuoqin Tang, PLA General Hospital, China

    14:40-15:05 Subsets of regulatory T cells and their roles in allergyHuiyun Zhang, Liaoning Medical University, China

    15:05-15:30 Validating the efficacy of the human embryonic stem cell (hESC) therapy in cerebral palsy patients Geeta Shroff, Nutech Mediworld, IndiaNetworking & Refreshments 15:30-15:50 @ Foyer

    15:50-16:15Potential clinical applications PG2 (Astralagus polysaccharide) in cancer related fatigue and immune modulationChi-Tai Yeh, Tapei Medical University-Shuang Ho Hospital, Taiwan

    16:15-16:40Treatment of CD20-directed chimeric antigen receptor-modified T cells in patients with relapsed or refractory B-cell Non-Hodgkin lymphoma: A early phase IIa trial reportWei-Dong Han, Chinese PLA General Hospital, China

    16:40-17:05Expressing membrane antibody reporter in the islet cells of non-obese diabetic mice to non-invasive image the disease progression of autoimmune diabetesKuo-Hsiang Chaung, Taipei Medical University, Taiwan

    17:05-17:30Mechanisms involved in memory promoting effect of Jobelyn ® in mice exposed to unpredictable chronic mild stress Solomon Umukoro, University of Ibadan, Nigeria

    Panel Discussion

    Opening Ceremony09:00-09:30

    Scientific Program

    Keynote Forum Introduction09:30-10:10 Alina Borkowska Nicolaus Copernicus University in Torun, Poland10:10-10:50 Alexander Melerzanov Moscow Institute of Physics and Technology, Russia

    Networking & Refreshments 10:50-11:10 @ Foyer

    http://translationalmedicine.conferenceseries.com/speaker/2015/alina-borkowska-nicolaus-copernicus-university-in-toru-polandhttp://translationalmedicine.conferenceseries.com/speaker/2015/alexander-melerzanov-moscow-institute-of-physics-and-technology-russiahttp://translationalmedicine.conferenceseries.com/abstract/2015/antibody-proteases-as-promising-tools-of-novel-generation-to-be-translated-into-clinical-practice-for-having-multistep-subclinical-and-clinical-demyelination-monitoring-securedhttp://translationalmedicine.conferenceseries.com/speaker/2015/sergey-suchkov-a-i-evdokimov-moscow-state-university-of-medicine-and-dentistry-russiahttp://translationalmedicine.conferenceseries.com/abstract/2015/use-of-engineered-mesenchymal-stem-cells-against-cancershttp://translationalmedicine.conferenceseries.com/speaker/2015/isabelle-de-waziers-inserm-u1147-francehttp://translationalmedicine.conferenceseries.com/abstract/2015/identification-of-genetic-variations-associated-with-outcome-risk-in-colorectal-cancer-where-are-we-nowhttp://translationalmedicine.conferenceseries.com/speaker/2015/sevtap-savas-university-of-newfondland-r-ncanadahttp://translationalmedicine.conferenceseries.com/abstract/2015/rrx-001-a-novel-ros-mediated-epigenetic-modulator-episensitization-to-previously-failed-therapieshttp://translationalmedicine.conferenceseries.com/speaker/2015/jan-scicinski-epicentrx-inc-mexicohttp://translationalmedicine.conferenceseries.com/abstract/2015/from-chromosomal-instability-to-metastases-h19-s-role-in-cancer-progression-and-its-clinical-significancehttp://translationalmedicine.conferenceseries.com/speaker/2015/eli-raveh-the-hebrew-university-of-jerusalem-israelhttp://translationalmedicine.conferenceseries.com/abstract/2015/survivin-sirna-nano-particles-are-capable-of-inhibiting-cancer-cell-growth-both-in-vitro-and-in-vivohttp://translationalmedicine.conferenceseries.com/speaker/2015/suoqin-tang-pla-general-hospital-chinahttp://translationalmedicine.conferenceseries.com/abstract/2015/subsets-of-regulatory-t-cells-and-their-roles-in-allergyhttp://translationalmedicine.conferenceseries.com/speaker/2015/huiyun-zhang-liaoning-medical-university-chinahttp://translationalmedicine.conferenceseries.com/abstract/2015/validating-the-efficacy-of-the-human-embryonic-stem-cell-hesc-therapy-in-cerebral-palsy-patientshttp://translationalmedicine.conferenceseries.com/speaker/2015/geeta-shroff-nutech-mediworld-indiahttp://translationalmedicine.conferenceseries.com/abstract/2015/potential-clinical-application-of-pg2-astragalus-polysaccharide-in-cancer-related-fatigue-and-immune-modulationhttp://translationalmedicine.conferenceseries.com/speaker/2015/chi-tai-yeh-taipei-medical-university-taiwanhttp://translationalmedicine.conferenceseries.com/abstract/2015/treatment-of-cd20-directed-chimeric-antigen-receptor-modified-t-cells-in-patients-with-relapsed-or-refractory-b-cell-non-hodgkin-lymphoma-a-early-phase-iia-trial-reporthttp://translationalmedicine.conferenceseries.com/speaker/2015/wei-dong-han-chinese-pla-general-hospital-chinahttp://translationalmedicine.conferenceseries.com/abstract/2015/expressing-membrane-antibody-reporter-in-the-islet-cells-of-nonobese-diabetic-mice-to-noninvasive-image-the-disease-progression-of-autoimmune-diabeteshttp://translationalmedicine.conferenceseries.com/speaker/2015/kuo-hsiang-chuang-taipei-medical-university-taiwanhttp://translationalmedicine.conferenceseries.com/abstract/2015/mechanisms-involved-in-memory-promoting-effect-of-jobelyn-in-mice-exposed-to-unpredictable-chronic-mild-stresshttp://translationalmedicine.conferenceseries.com/speaker/2015/solomon-umukoro-university-of-ibadan-nigeria

  • Page 3

    Day 2 October 27, 2015Chesapeak HallKeynote Forum

    09:30-10:10 Sergey Suchkov I M Sechenov First Moscow State Medical University, Russia10:10-10:50 Rajendra Bhimma University of KwaZulu-Natal, South Africa

    Networking & Refreshments 10:50-11:10 @ FoyerTrack 1: Biomarkers in Translational Medicine Track 3: Translational Cardiology and Vascular Medicine Track 6: Clinical EpidemiologySession Chair: Sevtap Savas, Memorial University of Newfondland, CanadaSession Co-Chair: Rajendra Bhimma, University of KwaZulu-Natal, South Africa

    Session Introduction11:10-11:35 Postoperative cognitive dysfunctions after cardiac operations Alina Borkowska, Nicolaus Copernicus University in Torun, Poland

    11:35-12:00Novel therapeutic approach of using high DHA omega-3 fatty acids to prevent vaso occlusive crisis in patients with sickle cell diseaseAhmed Daak, Sancilio & Company Inc., USA

    12:00-12:25 Urinary tract infection in children: A changing paradigmRajendra Bhimma, University of KwaZulu-Natal, South Africa12:25-12:50 Telomere length and lifestyle factors in breast cancer patientsKaoutar Ennour-Idrissi, Laval University, Canada

    Lunch Break 12:50-13:50 @ Eden's Landing Restaurant13:50-14:15 New marker of metabolic syndromeDavid Stejskal, Agel Research and Training Institute, Czech Republic

    14:15-14:40Lung neuroendocrine tumors: Correlation of ubiquitinylation and sumoylation with nucleo-cytosolic partitioning of PTENAlex Soltermann, University Hospital of Zurich, Switzerland

    14:40-15:05 Initial approach on the characterization of cardio-mesenchymal stem cellsJose R Navvaro, Panamerican University School of Medicine, Mexico

    15:05-15:30Hr–HPV: Distribution of high risk human papillomavirus strains in young women of KwaZulu- Natal, South Africa: Implications for vaccinationZL Mkhize Kwitshana, Mangosuthu University of Technology, South Africa

    15:30-15:55 Translational research and development of drugs :Translatability assessmentMartin Wehling, University of Heidelberg, GermanyNetworking & Refreshments15:55-16:15 @ Foyer

    Poster Presentations @ 16:15-17:15Panel Discussion

    Day 3 October 28, 2015Chesapeak Hall

    Track 2: Role of Translational Research in Blood Disorders Track 7: Translational of Animal Models to Clinic Track 10: Advances in Translational MedicineSession Chair: Ahmed Daak, Sancilio & Company Inc., USASession Co-Chair: Zijun Zhang, MedStar Union Memorial Hospital, USA

    Session Introduction09:30-09:55 A phase 3 study of L glutamine therapy for sickle cell anemia and sickle ß0-thalassemiaYutaka Niihara, Dawvid Geffen School of Medicine at UCLA, USA09:55-10:20 The concept of recycling translational medicineSeung Eun Choi, Healthcare Company, Korea10:20-10:45 TSG-6 induces liver regeneration by enhancing autophagy in mice with chronic liver damage Youngmi Jung, Pusan National University, Korea

    Networking & Refreshments10:45-11:05 @ Foyer

    11:05-11:30Implantation of autologous adipose tissue-derived mesenchymal stem cells in foot fat pad in ratsZijun Zhang, MedStar Union Memorial Hospital, USA

    11:30-11:55Extraction and characterization of bioactives from marine sources; A concept of modern research and drug discoveryHafiz Ansar Rasul Suleria, University of Queensland, Australia

    http://translationalmedicine.conferenceseries.com/speaker/2015/sergey-suchkov-i-m-sechenov-first-moscow-state-medical-university-russia-915746996http://translationalmedicine.conferenceseries.com/speaker/2015/rajendra-bhimma-university-of-kwazulu-natal-south-africahttp://translationalmedicine.conferenceseries.com/abstract/2015/postoperative-cognitive-dysfunctions-after-cardiac-operationshttp://translationalmedicine.conferenceseries.com/speaker/2015/alina-borowska-nicolaus-copernicus-university-polandhttp://translationalmedicine.conferenceseries.com/abstract/2015/novel-therapeutic-approach-of-using-high-dha-omega-3-fatty-acids-to-prevent-vaso-occlusive-crisis-in-patients-with-sickle-cell-diseasehttp://translationalmedicine.conferenceseries.com/speaker/2015/ahmed-daak-sancilio-company-usahttp://translationalmedicine.conferenceseries.com/abstract/2015/urinary-tract-infections-in-children-a-changing-paradigmhttp://translationalmedicine.conferenceseries.com/speaker/2015/rajendra-bhimma-university-of-kwa-zulu-natal-r-nsouth-africahttp://translationalmedicine.conferenceseries.com/abstract/2015/telomere-length-and-lifestyle-factors-in-breast-cancer-patientshttp://translationalmedicine.conferenceseries.com/speaker/2015/kaoutar-ennour-idrissi-laval-university-canadahttp://translationalmedicine.conferenceseries.com/abstract/2015/new-marker-of-metabolic-syndromehttp://translationalmedicine.conferenceseries.com/speaker/2015/david-stejskal-agel-research-and-training-institute-czech-republichttp://translationalmedicine.conferenceseries.com/abstract/2015/lung-neuroendocrine-tumors-correlation-of-ubiquitinylation-and-sumoylation-with-nucleo-cytosolic-partitioning-of-ptenhttp://translationalmedicine.conferenceseries.com/speaker/2015/alex-soltermann-university-hospital-zurich-switzerlandhttp://translationalmedicine.conferenceseries.com/abstract/2015/initial-approach-on-the-characterization-of-cardiomesenchymal-stem-cellshttp://translationalmedicine.conferenceseries.com/speaker/2015/jose-r-navarro-panamerican-university-school-of-medicine-usahttp://translationalmedicine.conferenceseries.com/abstract/2015/hr-hpv-distribution-of-high-risk-human-papillomavirus-strains-in-young-women-of-kwazulu-natal-south-africa-implications-for-vaccinationhttp://translationalmedicine.conferenceseries.com/speaker/2015/zl-mkhize-kwitshana-mangosuthu-university-of-technology-south-africahttp://translationalmedicine.conferenceseries.com/abstract/2015/translational-research-and-development-of-drugs-translatability-assessmenthttp://translationalmedicine.conferenceseries.com/speaker/2015/martin-wehling-university-of-heidelberg-germanyhttp://translationalmedicine.conferenceseries.com/abstract/2015/a-phase-3-study-of-l-glutamine-therapy-for-sickle-cell-anemia-and-sickle-ss0-thalassemiahttp://translationalmedicine.conferenceseries.com/speaker/2015/yutaka-niihara-david-geffen-school-of-medicine-ucla-usahttp://translationalmedicine.conferenceseries.com/abstract/2015/the-concept-of-recycling-translational-medicinehttp://translationalmedicine.conferenceseries.com/speaker/2015/seung-eun-choi-healthcare-company-koreahttp://translationalmedicine.conferenceseries.com/abstract/2015/tsg-6-induces-liver-regeneration-by-enhancing-autophagy-in-mice-with-chronic-liver-damagehttp://translationalmedicine.conferenceseries.com/speaker/2015/youngmi-jung-pusan-national-university-koreahttp://translationalmedicine.conferenceseries.com/abstract/2015/implantation-of-autologous-adipose-tissue-derived-mesenchymal-stem-cells-in-foot-fat-pad-in-ratshttp://translationalmedicine.conferenceseries.com/speaker/2015/zijun-zhang-medstar-union-memorial-hospital-r-nusahttp://translationalmedicine.conferenceseries.com/abstract/2015/extraction-and-characterization-of-bioactives-from-marine-sources-a-concept-of-modern-research-and-drug-discoveryhttp://translationalmedicine.conferenceseries.com/speaker/2015/hafiz-ansar-rasul-suleria-the-university-of-queensland-australia

  • Page 4

    11:55-12:20Evaluating the role of indirect bilirubin and urobilinogen as an alternative screening tool for beta thalassemia minorRidham Khanderia, Pandit Deendayal Medical College, India

    Lunch Break: 12:20-13:20 @ Eden's Landing RestaurantPanel Discussion

    Closing & Award ceremony

    Bookmark your dates

    November 17-19, 2016 San Francisco, USATranslational Medicine5th International Conference on

    Website: translationalmedicine.conferenceseries.come-mail: [email protected]; [email protected]